US Patent Family Members and Approved Drugs for Japan Patent: 2021500896
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Japan Patent: JP2021500896
| US Patent Number | Estimated Patent Expiration | Generic Name | US Applicant | US Tradename |
|---|---|---|---|---|
| 10,787,671 | 2037-10-27 | asparaginase erwinia chrysanthemi (recombinant)-rywn | Jazz Pharmaceuticals Ireland Limited | RYLAZE |
| >US Patent Number | >Estimated Patent Expiration | >Generic Name | >US Applicant | >US Tradename |
